News/ News/ Oncology Valirx eyes partnerships as first VAL201 study hits the mark Phil Taylor clinical trial, Oncology, Prostate cancer, Valirx 0 Comment Shares in UK biotech Valirx were up sharpy this morning after its lead drug VAL201 showed evidence of Share X Valirx eyes partnerships as first VAL201 study hits the mark https://pharmaphorum.com/news/valirx-eyes-partnerships-as-first-val201-study-hits-the-mark/
